Stratasys (SSYS) 6-K 3 Aug 22 Condensed Consolidated Interim Financial Statements Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2022
Document Information Line Items
Entity Registrant Name	STRATASYS LTD.
Document Type	6-K
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001517396
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity File Number	001-35751
Entity Address, Address Line One	1 Holtzman Street
Entity Address, Address Line Two	Science Park
Entity Address, Address Line Three	P.O. Box 2496
Entity Address, City or Town	Rehovot
Entity Address, Country	IL
Entity Address, Postal Zip Code	76124

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 255,886	$ 243,179
Short-term deposits	182,429	259,000
Accounts receivable, net of allowance for credit losses of $1.0 million and $0.5 million as of June 30, 2022 and December 31, 2021	132,343	129,382
Inventories	153,702	129,147
Prepaid expenses	8,225	6,871
Other current assets	49,615	33,123
Total current assets	782,200	800,702
Non-current assets
Property, plant and equipment, net	192,630	203,295
Goodwill	64,959	65,144
Other intangible assets, net	133,657	152,244
Operating lease right-of-use assets	12,319	14,651
Long-term investments	31,191	28,667
Other non-current assets	12,886	12,519
Total non-current assets	447,642	476,520
Total assets	1,229,842	1,277,222
Current liabilities
Accounts payable	61,316	51,976
Accrued expenses and other current liabilities	52,049	55,358
Accrued compensation and related benefits	30,513	44,684
Deferred revenues - short term	49,511	51,174
Operating lease liabilities - short term	6,111	7,276
Total current liabilities	199,500	210,468
Non-current liabilities
Deferred revenues - long term	22,727	21,133
Deferred income taxes - long term	4,511	7,341
Operating lease liabilities - long term	6,165	7,693
Contingent consideration - long term	50,299	53,478
Other non-current liabilities	22,931	21,095
Total non-current liabilities	106,633	110,740
Total liabilities	306,133	321,208
Contingencies (see note 12)
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousand shares; 66,744 thousand shares and 65,677 thousand shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	186	182
Additional paid-in capital	3,030,088	3,012,481
Accumulated other comprehensive loss	(13,354)	(8,771)
Accumulated deficit	(2,093,211)	(2,047,878)
Total equity	923,709	956,014
Total liabilities and equity	$ 1,229,842	$ 1,277,222

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parentheticals)	Jun. 30, 2022 USD ($) shares	Jun. 30, 2022 ₪ / shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2021 ₪ / shares
Statement of Financial Position [Abstract]
Accounts receivable, net of allowance for credit losses (in Dollars) | $	$ 1,000		$ 500
Ordinary shares, par value (in New Shekels per share) | ₪ / shares		₪ 10		₪ 10
Ordinary shares, authorized	180,000		180,000
Ordinary shares, issued	66,744		65,677
Ordinary shares, outstanding	66,744		65,677

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues
Revenues	$ 166,603	$ 147,005	$ 330,032	$ 281,194
Cost of revenues
Cost of revenues	99,210	83,735	192,962	162,347
Gross profit	67,393	63,270	137,070	118,847
Operating expenses
Research and development, net	24,346	22,437	48,344	43,038
Selling, general and administrative	66,592	63,557	131,855	116,891
Total operating expenses	90,938	85,994	180,199	159,929
Operating loss	(23,545)	(22,724)	(43,129)	(41,082)
Financial expenses, net	(1,170)	(372)	(2,532)	(749)
Loss before income taxes	(24,715)	(23,096)	(45,661)	(41,831)
Income tax benefit	429	4,368	502	5,310
Share in losses of associated companies	(99)	(1,431)	(174)	(2,549)
Net loss	$ (24,385)	$ (20,159)	$ (45,333)	$ (39,070)
Net loss per share - basic and diluted (in Dollars per share)	$ (0.37)	$ (0.31)	$ (0.69)	$ (0.63)
Weighted average ordinary shares outstanding. - basic and diluted (in Shares)	66,568	64,908	66,151	61,796
Comprehensive loss
Net loss	$ (24,385)	$ (20,159)	$ (45,333)	$ (39,070)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(2,789)	1,103	(3,491)	142
Unrealized gains (losses) on derivatives designated as cash flow hedges	(741)	(172)	(1,092)	2,001
Other comprehensive income (loss), net of tax	(3,530)	931	(4,583)	2,143
Comprehensive loss	(27,915)	(19,228)	(49,916)	(36,927)
Products
Revenues
Revenues	115,721	100,305	228,794	190,629
Cost of revenues
Cost of revenues	61,132	49,731	120,505	96,651
Services
Revenues
Revenues	50,882	46,700	101,238	90,565
Cost of revenues
Cost of revenues	$ 38,078	$ 34,004	$ 72,457	$ 65,696

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated deficit	Accumulated Other Comprehensive Loss	Total
Balance at Dec. 31, 2020	$ 155	$ 2,753,955	$ (1,985,896)	$ (8,846)	$ 759,368
Balance (in Shares) at Dec. 31, 2020	56,617
Issuance of shares in connection with stock-based compensation plans	$ 2	2,881			2,883
Issuance of shares in connection with stock-based compensation plans (in Shares)	670
Stock-based compensation		7,205			7,205
Public offering of ordinary shares, net	$ 24	218,851			218,875
Public offering of ordinary shares, net (in Shares)	7,931
Deferred tax assets in connection with public offering expenses		1,156			1,156
Comprehensive income (loss)			(18,911)	1,212	(17,699)
Balance at Mar. 31, 2021	$ 181	2,984,048	(2,004,807)	(7,634)	971,788
Balance (in Shares) at Mar. 31, 2021	65,218
Issuance of shares in connection with stock-based compensation plans		633			633
Issuance of shares in connection with stock-based compensation plans (in Shares)	178
Stock-based compensation		7,977			7,977
Deferred tax assets in connection with public offering expenses		175			175
Comprehensive income (loss)			(20,159)	931	(19,228)
Balance at Jun. 30, 2021	$ 181	2,992,833	(2,024,966)	(6,703)	961,345
Balance (in Shares) at Jun. 30, 2021	65,396
Balance at Dec. 31, 2021	$ 182	3,012,481	(2,047,878)	(8,771)	956,014
Balance (in Shares) at Dec. 31, 2021	65,677
Issuance of shares in connection with stock-based compensation plans	$ 3	152			155
Issuance of shares in connection with stock-based compensation plans (in Shares)	731
Stock-based compensation		8,533			8,533
Comprehensive income (loss)			(20,948)	(1,053)	(22,001)
Balance at Mar. 31, 2022	$ 185	3,021,166	(2,068,826)	(9,824)	942,701
Balance (in Shares) at Mar. 31, 2022	66,408
Issuance of shares in connection with stock-based compensation plans	$ 1	91			92
Issuance of shares in connection with stock-based compensation plans (in Shares)	336
Stock-based compensation		8,831			8,831
Comprehensive income (loss)			(24,385)	(3,530)	(27,915)
Balance at Jun. 30, 2022	$ 186	$ 3,030,088	$ (2,093,211)	$ (13,354)	$ 923,709
Balance (in Shares) at Jun. 30, 2022	66,744

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities
Net loss	$ (45,333)	$ (39,070)
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment of other long-lived assets	3,865
Depreciation and amortization	29,924	27,695
Stock-based compensation	17,364	15,182
Foreign currency transaction loss	10,318	3,311
Share in loss of associated companies	174	2,549
Revaluation of investments	2,316	(1,469)
Other non-cash items, net	168	1,152
Change in cash attributable to changes in operating assets and liabilities:
Accounts receivable, net	(11,058)	(4,272)
Inventories	(39,162)	5,772
Other current assets and prepaid expenses	5,320	(5,066)
Other non-current assets	382	2,561
Accounts payable	10,217	24,019
Other current liabilities	(20,650)	4,804
Deferred revenues	4,540	514
Deferred income taxes, net and uncertain tax positions	(1,674)	(5,574)
Other non-current liabilities	(5,620)	(3,722)
Net cash provided by (used in) operating activities	(38,909)	28,386
Cash flows from investing activities
Cash paid for acquisitions, net of cash acquired		(6,669)
Purchase of property and equipment	(7,526)	(11,358)
Investments in short-term bank deposits	(195,429)	(179,000)
Proceeds from short-term bank deposits	272,000	27,000
Purchase of intangible assets	(965)	(564)
Other investing activities	122	(85)
Investments in unconsolidated entities	(5,030)	(7,000)
Net cash provided by (used in) investing activities	63,172	(177,676)
Cash flows from financing activities
Proceeds from public offering, net of issuance costs		218,875
Proceeds from exercise of stock options	247	3,516
Payment of contingent consideration	(1,386)
Other financing activities	275	405
Net cash provided by (used in) financing activities	(864)	222,796
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(7,413)	(1,869)
Net change in cash, cash equivalents and restricted cash	15,986	71,637
Cash, cash equivalents and restricted cash, beginning of period	243,293	272,216
Cash, cash equivalents and restricted cash, end of period	259,279	343,853
Supplemental disclosures of cash flow information:
Transfer of inventory to fixed assets	1,150	2,024
Transfer of fixed assets to inventory	123	252
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:
Cash and cash equivalents	255,886	343,733
Restricted cash included in other current assets	160	120
Cash balances classified as Held for sale	3,233
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows	$ 259,279	$ 343,853

Business Description and Basis

Business Description and Basis of Presentation	6 Months Ended
	Jun. 30, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Business Description and Basis of Presentation	Note 1. Business Description and Basis of Presentation Stratasys Ltd. (collectively with its subsidiaries, the “Company” or “Stratasys”) is a global leader in connected, polymer-based 3D printing solutions, across the entire manufacturing value chain. The Company leverages its competitive advantages, which include a broad set of best-in-class 3D printing platforms, software, a materials and technology partner ecosystem, innovative leadership, and global GTM infrastructure, in order to position itself to capture share in a significant and growing global marketplace, with a focus on manufacturing. The condensed consolidated interim financial information herein is unaudited; however, such information reflects all adjustments (consisting of normal, recurring adjustments), which are, in the opinion of management, necessary for a fair statement of results for the interim period. The condensed consolidated interim financial statements include the accounts of Stratasys Ltd. and its subsidiaries. All intercompany accounts and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated in consolidation. The Company’s financial statements are prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), which require the Company to make estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in its financial statements. Although the Company’s current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from the Company’s expectations, which could materially affect its results of operations and financial position. In particular, a number of estimates have been and will continue to be affected by the COVID-19 pandemic and/or by macroeconomic conditions that have been triggered as a result of the pandemic or steps taken to counter it. The global economic environment that has set in after the most severe period of the COVID-19 pandemic has passed - assuming that it has passed - remains uncertain, rapidly changing and difficult to predict. The magnitude and duration of, as well as the consequences of, global macroeconomic trends triggered, in large part, by the recovery from the pandemic, such as inflationary pressures and supply chain problems, The results of operations for the three and six months ended June 30, 2022 are not indicative of results that could be expected for the entire fiscal year. Certain financial information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The reader is referred to the audited consolidated financial statements and notes thereto for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 24, 2022 as part of the Company’s Annual Report on Form 20-F for such year.

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
	Jun. 30, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	Note 2. New Accounting Pronouncements Accounting Pronouncements Adopted in 2022 In August 2020, the FASB issued ASU 2020-06 “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40).” This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The amendments to this guidance are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2022, with no material impact on its consolidated financial statements. Recently issued accounting pronouncements not yet adopted In October 2021, the FASB issued ASU 2021-08 “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. The guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. The guidance should be applied prospectively to acquisitions occurring on or after the effective date. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company is currently evaluating this guidance to determine the impact it may have on its consolidated financial statements.

Certain Transactions

Certain Transactions	6 Months Ended
	Jun. 30, 2022
Certain Transactions [Abstract]
Certain Transactions	Note 3. Certain Transactions Investment in Xaar 3D Ltd. ("Xaar 3D") During the fourth quarter of 2019, the Company entered into an agreement with Xaar plc (“Xaar”) to purchase additional shares of Xaar 3D that would increase its stake from 15 to 45 percent, with Xaar retaining the remaining 55 percent. Xaar and Stratasys had announced the formation of Xaar 3D Ltd in July 2018 for the purpose of developing Powder Bed Fusion (“PBF”) additive manufacturing solutions that Stratasys can bring to the market. In addition, the agreement included an option for Stratasys to acquire the remaining shares of Xaar 3D. Following the additional investment, the Company considered the FASB guidance in accordance with ASC Topic 810 “Consolidation” regarding the propriety of implementing consolidation, for both the variable interest entity and voting model, or equity method accounting. The Company concluded that it should continue accounting for the investment according to the equity method, as it had retained the ability to exercise significant influence but did not control Xaar 3D. For its additional interest in Xaar 3D, the Company paid approximately $15.7 million. The investment was presented under other non-current assets in the Company’s consolidated balance sheets. On November 1, 2021 (the “Xaar 3D transaction date”) , the Company acquired the remaining 55% share of Xaar 3D, for an aggregate purchase price of $29.3 million. The Company paid cash upon closing and it is obligated to make additional earn-out payments and payments of royalties on products and services sales for up to 15 years. The Xaar 3D transaction is reflected in accordance with ASC Topic 805, “Business Combinations”, using the acquisition method of accounting, with the Company as the acquirer. The Company accounted for the acquisition of the remaining equity of Xaar 3D as a step acquisition, which required re-measurement of the Company’s previous ownership interest to fair value prior to completing purchase accounting. Using step acquisition accounting, the Company increased the value of its previously-held equity investment to its fair value of $23.8 million, which resulted in a gain of approximately $14.4 million, recorded in the consolidated statements of operations in the fourth quarter of 2021. The acquisition of the remaining equity interest also resulted in the recognition of a previously unrealized foreign currency gain of $0.6 million, The following table summarizes the fair value of the consideration transferred to Xaar 3D’s stockholders for the Xaar 3D transaction: U.S. $ in thousands Cash payments $ 13,967 Contingent consideration at estimated fair value 15,314 Total consideration for 55% holding 29,281 Fair value of 45% holding 23,775 Total consideration $ 53,056 In accordance with ASC Topic 805, the estimated contingent consideration as of the Xaar 3D transaction date was included in the purchase price. The total contingent payments could reach a maximum aggregate amount of up to $21 million. The estimated fair value of the contingent consideration is based on management’s assessment of whether, and at what level, the financial metrics will be achieved, and the present value factors associated with the timing of the payments. This fair value measurement is based on significant unobservable inputs in the market and thus represents a Level 3 measurement within the fair value hierarchy. Changes in the fair value of contingent consideration will be recorded in operating expenses. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Xaar 3D transaction date. The estimated fair values are preliminary and based on the information that was available as of November 1, 2021. Thus, the measurements of fair value that are reflected are subject to changes, and such changes could be significant. The preliminary allocation of the purchase price to assets acquired and liabilities assumed is as follows: Allocation of Purchase Price (U.S. $ in thousands) Cash and cash equivalents $ 82 Goodwill 25,375 Intangible assets 45,000 Other assets 5,280 Total assets acquired 75,737 Net deferred tax liabilities 1,736 Other labilities 20,945 Total liabilities assumed 22,681 Net assets acquired $ 53,056 RPS acquisition On February 16, 2021 the Company acquired RP Support Lim ited (“RPS”), a provider of industrial stereolithography 3D printers and solutions. In exchange for 100% of the outstanding shares of RPS, the Company paid cash upon closing and is obligated to make additional payments (in cash), subject to performance-based criteria, via earn-out payments over two years. M arketable equity investment The Company recognized losses for the revaluation of an equity investment, in amounts of $1.3 million and $2.9 million in the three-month periods ended June 30, 2022 and 2021, respectively. A loss of $2.3 million and a gain of $0.7 million were recognized in the six-month periods ended June 30, 2022 and 2021, respectively. The entity in which the Company invested became public during the first quarter of 2021 and accordingly the investment is treated as a marketable equity investment. Prior to the first quarter of 2021, the investment was treated as a non-marketable equity investment without readily determinable fair value. MakerBot and Ultimaker transaction In connection with this transaction, the Company expects to record a gain from deconsolidation of MakerBot representing the difference between the book value of MakerBot's net assets and the fair value allocated to such net assets in the transaction. In accordance with ASC Topic 360, MakerBot’s assets and liabilities are classified as held for sale. The held for sale assets and liabilities are presented under Other current assets ($23.5 million) and Accrued expenses and other current liabilities ($10.1 million), respectively, in the Company's consolidated balance sheets as of June 30, 2022.

Revenues

Revenues	6 Months Ended
	Jun. 30, 2022
Revenue Recognition [Abstract]
Revenues	Note 4. Revenues Disaggregation of Revenues The following table presents the Company’s revenues disaggregated by geographical region (based on the Company's customers' locations) and revenue type for the three and six months ended June 30, 2022 and 2021: Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 (U.S. $ in thousands) (U.S. $ in thousands) Americas Systems $ 32,868 $ 27,053 $ 61,850 $ 48,410 Consumables 34,662 30,730 66,016 58,941 Service 39,695 35,166 77,926 67,711 Total Americas 107,225 92,949 205,792 175,062 EMEA Systems 14,760 10,481 29,837 20,179 Consumables 14,268 15,345 32,093 28,148 Service 6,184 6,697 13,337 13,114 Total EMEA 35,212 32,523 75,267 61,441 Asia Pacific Systems 11,235 8,031 21,693 16,856 Consumables 7,928 8,665 17,305 18,095 Service 5,003 4,837 9,975 9,740 Total Asia Pacific 24,166 21,533 48,973 44,691 Total Revenues $ 166,603 $ 147,005 $ 330,032 $ 281,194 The following table presents the Company’s revenues disaggregated based on the timing of revenue recognition (at a specific point in time or over the course of time) for the three and six months ended June 30, 2022 and 2021: Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 (U.S. $ in thousands) (U.S. $ in thousands) Revenues recognized in point in time from: Products $ 115,721 $ 100,305 $ 228,794 $ 190,629 Services 13,147 11,124 25,639 21,725 Total revenues recognized in point in time 128,868 111,429 254,433 212,354 Revenues recognized over time from: Services 37,735 35,576 75,599 68,840 Total revenues recognized over time 37,735 35,576 75,599 68,840 Total Revenues $ 166,603 $ 147,005 $ 330,032 $ 281,194 Contract Assets and Contract Liabilities Contract assets are recorded when the Company's right to consideration is conditioned on constraints other than the passage of time. The Company had no material contract assets as of June 30, 2022 and December 31, 2021. Contract liabilities include advance payments and billings in excess of revenue recognized, which are primarily related to advanced billings for service type warranty. Contract liabilities are presented under deferred revenues. The Company's deferred revenues as of June 30, 2022 and December 31, 2021 were as follows: June 30, 2022 December 31, 2021 U.S. $ in thousands Deferred revenue* $ 72,238 $ 72,307 *Includes $22.7 million and $21.1 million under long-term deferred revenue in the Company's consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively. Revenue recognized in 2022 that was included in deferred revenue balance as of December 31, 2021 was $12.9 $30.5 million Remaining Performance Obligations Remaining Performance Obligations ( “ “ . As of June 30, 2022, the total RPO amounted to $112.7 million. The Company expects to recognize $89.5 million of this RPO during the next 12 months, $16.2 million over the subsequent 12 months and the remaining $6.9 million thereafter. Incremental Costs of Obtaining a Contract Sales commissions earned mainly by the Company’s sales agents are considered incremental costs of obtaining a contract with a customer, as the Company expects the benefit of those commissions to be longer than one year. The majority of the sales commissions are not subject to capitalization, as the commission expense is recognized as the related revenue is recognized. Sales commissions for initial contracts related to the service type warranty are deferred and then amortized on a straight-line basis over the expected customer relationship period if the Company expects to recover those costs. Amortization expense is included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive loss. As of June 30, 2022 and December 31, 2021, the deferred commissions amounted to $8.4 million and $7.4 million, respectively.

Inventories

Inventories	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Note 5. Inventories Inventories consisted of the following as of the below balance sheet dates: June 30, 2022 December 31, 2021 U.S. $ in thousands Finished goods $ 64,897 $ 58,784 Work-in-process 6,218 4,360 Raw materials 82,587 66,003 $ 153,702 $ 129,147

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 6. Goodwill and Other Intangible Assets Goodwill Changes in the carrying amount of the Company’s goodwill during the six months ended June 30, 2022 were as follows: U.S. $ in thousands Goodwill as of January 1, 2022 $ 65,144 Foreign currency translation adjustments (185 ) Goodwill as of June 30, 2022 $ 64,959 Other Intangible Assets Other intangible assets consisted of the following: June 30, 2022 December 31, 2021 Carrying Amount, Net Carrying Amount, Net Net of Accumulated Book Net of Accumulated Book Impairment Amortization Value Impairment Amortization Value U.S. $ in thousands Developed technology $ 382,436 $ (269,440 ) $ 112,996 $ 406,578 $ (279,037 ) $ 127,541 Patents 15,567 (8,079 ) 7,488 16,220 (8,503 ) 7,717 Trademarks and trade names 16,732 (13,467 ) 3,265 26,055 (22,241 ) 3,814 Customer relationships 93,475 (83,567 ) 9,908 100,731 (87,559 ) 13,172 Capitalized software development costs 7,066 (7,066 ) - 7,410 (7,410 ) - $ 515,276 $ (381,619 ) $ 133,657 $ 556,994 $ (404,750 ) $ 152,244 Amortization expenses relating to intangible assets for the three-month periods ended June 30, 2022 and 2021 were approximately $9.2 million and $7.7 million, respectively. Amortization expenses relating to intangible assets for the six month periods ended June 30, 2022 and 2021 were approximately $18.4 million and $15.2 million, respectively. As of June 30, 2022, the estimated amortization expenses relating to intangible assets for each of the following future periods were as follows: Estimated amortization expense (U.S. $ in thousands) Remaining 6 months of 2022 $ 18,705 2023 22,058 2024 18,048 2025 15,577 2026 15,501 2027 and thereafter 43,768 Total $ 133,657

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Note 7. Net Loss Per Share The following table presents the numerator and denominator of the basic and diluted net loss per share computations for the three and six months ended June 30, 2022 and 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 In thousands, except per share amounts In thousands, except per share amounts Numerator: Net loss for basic and diluted net loss per share $ (24,385 ) $ (20,159 ) $ (45,333 ) $ (39,070 ) Denominator: Weighted average shares - for basic and diluted net loss per share 66,568 64,908 66,151 61,796 Net loss per share Basic and diluted $ (0.37 ) $ (0.31 ) $ (0.69 ) $ (0.63 ) The computation of diluted net loss per share excluded share awards of 5.2 million shares and 5.1 million shares for the three and six months ended June 30, 2022 and 2021, respectively, because their inclusion would have had an anti-dilutive effect on the diluted net loss per share.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 8. Income Taxes The Company had income tax benefit of $0.4 million for the three-month period ended June 30, 2022, compared to income tax benefit of $4.4 million for the three-month period ended June 30, 2021. The Company had income tax benefit of $0.5 million for the six-month period ended June 30, 2022, compared to income tax benefit of $5.3 million for the six-month period ended June 30, 2021 The Company’s effective tax rate as of June 30, 2022, was primarily impacted by the geographic mix of its earnings and losses, as well as its valuation allowance.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9. Fair Value Measurements Financial instruments measured at fair value The following table summarizes the Company’s financial assets and liabilities that are carried at fair value on a recurring basis, in its consolidated balance sheets: June 30, 2022 December 31, 2021 Level 2 Level 3 Level 2 Level 3 (U.S. $ in thousands) Assets: Foreign exchange forward contracts not designated as hedging instruments $ 244 $ - $ 82 $ - Foreign exchange forward contracts designated as hedging instruments 2,295 - 910 - Liabilities: Foreign exchange forward contracts not designated as hedging instruments (82 ) - (89 ) - Foreign exchange forward contracts designated as hedging instruments (2,715 ) - (60 ) - Total contingent consideration* - 55,108 - 55,919 $ (258 ) $ 55,108 $ 843 $ 55,919 *Includes $4.8 million and $2.4 million under Accrued expenses and other current liabilities in the Company's consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively. The Company’s foreign exchange forward contracts are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs, including interest rate curves and both forward and spot prices for currencies (Level 2 inputs). Contingent consideration represents liabilities recorded at fair value in connection with acquisitions, and thus represents a Level 3 measurement within the fair value hierarchy (refer to Note 3). Other financial instruments consist mainly of cash and cash equivalents, short-term deposits, current and non-current assets, accounts payable and other current liabilities. The fair value of these financial instruments approximates their carrying values.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative instruments and hedging activities	Note 10. Derivative instruments and hedging activities Since the Company conducts its operations globally, it is exposed to global market risks and to the risk that its earnings, cash flows and equity could be adversely impacted by fluctuations in foreign currency exchange rates. The Company enters into transactions involving foreign currency exchange derivative financial instruments. The Company manages its foreign currency exposures on a consolidated basis, which allows the Company to net exposures and take advantage of any natural hedging. The transactions are designed to manage the Company’s net exposure to foreign currency exchange rates and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not enter into derivative transactions for trading purposes. The Company is primarily exposed to foreign exchange risk with respect to recognized assets and liabilities and forecasted transactions denominated in the New Israeli Shekel (“NIS”), Euro, GBP, Korean Won, Chinese Yuan and the Japanese Yen. The gains and losses on the hedging instruments partially offset losses and gains on the hedged items. Financial markets and currency volatility may limit the Company’s ability to hedge these exposures. These contracts mature through June 2023. The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments: Fair Value Notional Amount June 30, December 31, June 30, December 31, Balance sheet location 2022 2021 2022 2021 U.S. $ in thousands Assets derivatives -Foreign exchange contracts, not designated as hedging instruments Other current assets $ 244 $ 82 $ 39,197 $ 12,380 Assets derivatives -Foreign exchange contracts, designated as cash flow hedge Other current assets 2,295 910 27,434 60,408 Liability derivatives -Foreign exchange contracts, not designated as hedging instruments Accrued expenses and other current liabilities (82 ) (89 ) 2,421 33,047 Liability derivatives -Foreign exchange contracts, designated as hedging instruments Accrued expenses and other current liabilities (2,715 ) (60 ) 35,121 26,320 $ (258 ) $ 843 $ 104,173 $ 132,155 Foreign exchange contracts not designated as hedging instruments As of June 30, 2022, the notional amounts of the Company’s outstanding exchange forward contracts, not designated as hedging instruments, were $41.6 million, and were used to reduce foreign currency exposures. With respect to such derivatives, gain of $2.4 million and loss of $0.5 million gain of $3.1 million and gain of $1.7 million were recognized under financial expenses, net for the six-month periods ended June 30, 2022 and 2021, respectively Cash Flow Hedging - Hedges of forecasted foreign currency payroll and other operating expenses As of June 30, 2022 Cash Flow Hedging - Hedges of forecasted foreign currency revenue As of June 30, 2022

Equity

Equity	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Equity	Note 11. Equity a. Stock-based compensation plans Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”), performance-based restricted share units ( ” ” Employee Share Purchase Plan Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 U.S $ in thousands U.S $ in thousands Cost of revenues $ 1,080 $ 788 $ 1,980 $ 1,422 Research and development, net 1,606 1,870 3,392 3,294 Selling, general and administrative 6,145 5,319 11,992 10,466 Total stock-based compensation expenses $ 8,831 $ 7,977 $ 17,364 $ 15,182 A summary of the Company’s stock option activity for the six months ended June 30, 2022 Number of Options Weighted Average Exercise Price Options outstanding as of January 1, 2021 1,732,368 28.85 Granted - - Exercised (21,240 ) 11.58 Forfeited (22,793 ) 23.06 Options outstanding as of June 30, 2022 1,688,335 29.15 Options exercisable as of June 30, 2022 1,374,113 32.04 As of June 30, 2022 A summary of the Company’s RSUs and PSUs activity for the six months ended June 30, 2022 Number of RSUs and PSUs Weighted Average Grant Date Fair Value Unvested as of January 1, 2022 3,082,798 26.36 Granted 1,741,710 22.43 Vested (1,030,907 ) 25.04 Forfeited (248,657 ) 24.56 Unvested as of June 30, 2022 3,544,944 24.94 The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant. As of June 30, 2022 Employee Stock Purchase Plan On October 2021, the Company adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). According to the ESPP, eligible employees may use up to 15% of their salaries to purchase ordinary shares. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the beginning of each offering period or on the purchase date. The first offering period commenced on June 1, 2022 and will end on November 30, 2022. In accordance with ASC Topic 718, the ESPP is considered compensatory and, as such, results in recognition of stock-based compensation expenses. The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the six months ended June 30, 2022 Six Months Ended June 30, 2022 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total U.S. $ in thousands Balance as of January 1, 2022 $ 1,572 $ (10,343 ) $ (8,771 ) Other comprehensive income (loss) before reclassifications (1,049 ) (3,491 ) (4,540 ) Amounts reclassified from accumulated other comprehensive loss (43 ) - (43 ) Other comprehensive loss (1,092 ) (3,491 ) (4,583 ) Balance as of June 30, 2022 $ 480 $ (13,834 ) $ (13,354 ) Six Months Ended June 30, 2021 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total U.S. $ in thousands Balance as of January 1, 2021 $ (1,673 ) $ (7,173 ) $ (8,846 ) Other comprehensive income before reclassifications 1,710 142 1,852 Amounts reclassified from accumulated other comprehensive loss 291 - 291 Other comprehensive income 2,001 142 2,143 Balance as of June 30, 2021 $ 328 $ (7,031 ) $ (6,703 ) c. Rights plan On July 24, 2022, the Company’s Board of Directors adopted a rights plan (the “Rights Plan”) to protect the interests of the Company’s shareholders. Each Right entitles the registered holder thereof to purchase from the Company one Ordinary Share at a price of $0.01 per share, subject to adjustment, once the Rights become exercisable, and subject to the exercise terms and conditions thereof described in the Rights Agreement. The rights would become exercisable only if an entity, person, or group acquires beneficial ownership of 15% or more of the Company’s outstanding ordinary shares in a transaction not approved by the Company’s Board. The Rights Plan has a 364-day term, expiring on July 24, 2023. The Rights Plan will encourage anyone seeking to gain a significant interest in Stratasys to negotiate directly with the Board prior to attempting to control or significantly influence the Company. Further to those goals, the Rights may cause substantial dilution to a person or group that acquires 15% or more of the ordinary shares, par value NIS 0.01, of the Company (“Ordinary Shares”) or any existing holder of 15% or more of the Ordinary Shares who shall acquire any additional Ordinary Shares. d. Public offering of ordinary shares During March 2021, the Company completed a public offering of its ordinary shares that raised $218.9 million, net of underwriting discounts and offering expenses. The total number of shares sold by the Company in the public offering was 7,931,034. A deferred tax asset in an amount of $1.3 million was recorded in respect of a tax benefit, arising from the underwriting discounts and offering expenses, as an increase to Additional Paid-In Capital.

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2022
Loss Contingency [Abstract]
Contingencies	Note 12. Contingencies Legal proceedings During the fourth quarter of 2021, the Company reached preliminary settlement on an employee-related litigation matter in the US. The financial statements for the period ended June 30, 2022 and the year ended December 31, 2021 include a provision in respect of this settlement. The Company is a party to various legal proceedings from time to time, the outcome of which, in the opinion of management, will not have a significant effect on the financial position, profitability or cash flows of the Company.

Certain Transactions (Tables)

Certain Transactions (Tables)	6 Months Ended
	Jun. 30, 2022
Certain Transactions [Abstract]
Schedule of fair value of the consideration transferred to xaar 3D’s stockholders for the xaar 3D transaction	U.S. $ in thousands Cash payments $ 13,967 Contingent consideration at estimated fair value 15,314 Total consideration for 55% holding 29,281 Fair value of 45% holding 23,775 Total consideration $ 53,056
Schedule of preliminary allocation of the purchase price to assets acquired and liabilities	Allocation of Purchase Price (U.S. $ in thousands) Cash and cash equivalents $ 82 Goodwill 25,375 Intangible assets 45,000 Other assets 5,280 Total assets acquired 75,737 Net deferred tax liabilities 1,736 Other labilities 20,945 Total liabilities assumed 22,681 Net assets acquired $ 53,056

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Schedule of disaggregated by geographical region	Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 (U.S. $ in thousands) (U.S. $ in thousands) Americas Systems $ 32,868 $ 27,053 $ 61,850 $ 48,410 Consumables 34,662 30,730 66,016 58,941 Service 39,695 35,166 77,926 67,711 Total Americas 107,225 92,949 205,792 175,062 EMEA Systems 14,760 10,481 29,837 20,179 Consumables 14,268 15,345 32,093 28,148 Service 6,184 6,697 13,337 13,114 Total EMEA 35,212 32,523 75,267 61,441 Asia Pacific Systems 11,235 8,031 21,693 16,856 Consumables 7,928 8,665 17,305 18,095 Service 5,003 4,837 9,975 9,740 Total Asia Pacific 24,166 21,533 48,973 44,691 Total Revenues $ 166,603 $ 147,005 $ 330,032 $ 281,194
Schedule of revenue recognition	Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 (U.S. $ in thousands) (U.S. $ in thousands) Revenues recognized in point in time from: Products $ 115,721 $ 100,305 $ 228,794 $ 190,629 Services 13,147 11,124 25,639 21,725 Total revenues recognized in point in time 128,868 111,429 254,433 212,354 Revenues recognized over time from: Services 37,735 35,576 75,599 68,840 Total revenues recognized over time 37,735 35,576 75,599 68,840 Total Revenues $ 166,603 $ 147,005 $ 330,032 $ 281,194
Schedule of changes in deferred revenue	June 30, 2022 December 31, 2021 U.S. $ in thousands Deferred revenue* $ 72,238 $ 72,307

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventories	June 30, 2022 December 31, 2021 U.S. $ in thousands Finished goods $ 64,897 $ 58,784 Work-in-process 6,218 4,360 Raw materials 82,587 66,003 $ 153,702 $ 129,147

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in the carrying amount of goodwill	U.S. $ in thousands Goodwill as of January 1, 2022 $ 65,144 Foreign currency translation adjustments (185 ) Goodwill as of June 30, 2022 $ 64,959
Schedule of other intangible assets	June 30, 2022 December 31, 2021 Carrying Amount, Net Carrying Amount, Net Net of Accumulated Book Net of Accumulated Book Impairment Amortization Value Impairment Amortization Value U.S. $ in thousands Developed technology $ 382,436 $ (269,440 ) $ 112,996 $ 406,578 $ (279,037 ) $ 127,541 Patents 15,567 (8,079 ) 7,488 16,220 (8,503 ) 7,717 Trademarks and trade names 16,732 (13,467 ) 3,265 26,055 (22,241 ) 3,814 Customer relationships 93,475 (83,567 ) 9,908 100,731 (87,559 ) 13,172 Capitalized software development costs 7,066 (7,066 ) - 7,410 (7,410 ) - $ 515,276 $ (381,619 ) $ 133,657 $ 556,994 $ (404,750 ) $ 152,244
Schedule of estimated amortization expense relating to intangible assets	Estimated amortization expense (U.S. $ in thousands) Remaining 6 months of 2022 $ 18,705 2023 22,058 2024 18,048 2025 15,577 2026 15,501 2027 and thereafter 43,768 Total $ 133,657

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of basic and diluted net loss per share	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 In thousands, except per share amounts In thousands, except per share amounts Numerator: Net loss for basic and diluted net loss per share $ (24,385 ) $ (20,159 ) $ (45,333 ) $ (39,070 ) Denominator: Weighted average shares - for basic and diluted net loss per share 66,568 64,908 66,151 61,796 Net loss per share Basic and diluted $ (0.37 ) $ (0.31 ) $ (0.69 ) $ (0.63 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities carried at fair value on a recurring basis	June 30, 2022 December 31, 2021 Level 2 Level 3 Level 2 Level 3 (U.S. $ in thousands) Assets: Foreign exchange forward contracts not designated as hedging instruments $ 244 $ - $ 82 $ - Foreign exchange forward contracts designated as hedging instruments 2,295 - 910 - Liabilities: Foreign exchange forward contracts not designated as hedging instruments (82 ) - (89 ) - Foreign exchange forward contracts designated as hedging instruments (2,715 ) - (60 ) - Total contingent consideration* - 55,108 - 55,919 $ (258 ) $ 55,108 $ 843 $ 55,919

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of balance sheet classification and fair values of derivative instruments	Fair Value Notional Amount June 30, December 31, June 30, December 31, Balance sheet location 2022 2021 2022 2021 U.S. $ in thousands Assets derivatives -Foreign exchange contracts, not designated as hedging instruments Other current assets $ 244 $ 82 $ 39,197 $ 12,380 Assets derivatives -Foreign exchange contracts, designated as cash flow hedge Other current assets 2,295 910 27,434 60,408 Liability derivatives -Foreign exchange contracts, not designated as hedging instruments Accrued expenses and other current liabilities (82 ) (89 ) 2,421 33,047 Liability derivatives -Foreign exchange contracts, designated as hedging instruments Accrued expenses and other current liabilities (2,715 ) (60 ) 35,121 26,320 $ (258 ) $ 843 $ 104,173 $ 132,155

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of stock-based compensation expenses	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 U.S $ in thousands U.S $ in thousands Cost of revenues $ 1,080 $ 788 $ 1,980 $ 1,422 Research and development, net 1,606 1,870 3,392 3,294 Selling, general and administrative 6,145 5,319 11,992 10,466 Total stock-based compensation expenses $ 8,831 $ 7,977 $ 17,364 $ 15,182
Schedule of stock option activity	Number of Options Weighted Average Exercise Price Options outstanding as of January 1, 2021 1,732,368 28.85 Granted - - Exercised (21,240 ) 11.58 Forfeited (22,793 ) 23.06 Options outstanding as of June 30, 2022 1,688,335 29.15 Options exercisable as of June 30, 2022 1,374,113 32.04
Schedule of RSUs and PSUs activity	Number of RSUs and PSUs Weighted Average Grant Date Fair Value Unvested as of January 1, 2022 3,082,798 26.36 Granted 1,741,710 22.43 Vested (1,030,907 ) 25.04 Forfeited (248,657 ) 24.56 Unvested as of June 30, 2022 3,544,944 24.94
Schedule of accumulated other comprehensive income (loss)	Six Months Ended June 30, 2022 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total U.S. $ in thousands Balance as of January 1, 2022 $ 1,572 $ (10,343 ) $ (8,771 ) Other comprehensive income (loss) before reclassifications (1,049 ) (3,491 ) (4,540 ) Amounts reclassified from accumulated other comprehensive loss (43 ) - (43 ) Other comprehensive loss (1,092 ) (3,491 ) (4,583 ) Balance as of June 30, 2022 $ 480 $ (13,834 ) $ (13,354 ) Six Months Ended June 30, 2021 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total U.S. $ in thousands Balance as of January 1, 2021 $ (1,673 ) $ (7,173 ) $ (8,846 ) Other comprehensive income before reclassifications 1,710 142 1,852 Amounts reclassified from accumulated other comprehensive loss 291 - 291 Other comprehensive income 2,001 142 2,143 Balance as of June 30, 2021 $ 328 $ (7,031 ) $ (6,703 )

Business Description and Basi_2

Business Description and Basis of Presentation (Details)	6 Months Ended
	Jun. 30, 2022
Business Combination [Member]
Business Description and Basis of Presentation (Details) [Line Items]
Business acquisition, description	The Company’s approximately 1,700 granted and pending additive technology patents to date have been used to create models, prototypes, manufacturing tools, and production parts for a multitude of industries including aerospace, automotive, transportation, healthcare, consumer products, dental, medical, and education.

Certain Transactions (Details)

Certain Transactions (Details) - USD ($) $ in Millions				3 Months Ended				6 Months Ended
	May 12, 2022	Nov. 01, 2021	Feb. 16, 2021	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2019	Jun. 30, 2022	Jun. 30, 2021
Certain Transactions (Details) [Line Items]
Aggregate purchase price		$ 29.3
Fair value					$ 23.8
Gain					$ 14.4
Changes in fair value of equity investment								$ 0.6
Total contingent payments aggregate amount								21
Exchange for outstanding shares, percentage			100%
Based earn-outs over term			2 years
Gain and loss equity investment				$ 1.3		$ 2.9
Debt and equity loss amount								2.3	$ 2.3
Debt equity gain amount								0.7	$ 0.7
Other current assets				23.5				23.5
Other current liabilities				$ 10.1				10.1
MakerBot [Member]
Certain Transactions (Details) [Line Items]
Equity method ownership percentage	45.60%
NPM Capital [Member]
Certain Transactions (Details) [Line Items]
Equity method ownership percentage	54.40%
Xaar 3D [Member]
Certain Transactions (Details) [Line Items]
Investment, description							During the fourth quarter of 2019, the Company entered into an agreement with Xaar plc (“Xaar”) to purchase additional shares of Xaar 3D that would increase its stake from 15 to 45 percent, with Xaar retaining the remaining 55 percent.
Additional interest amount								$ 15.7
Remaining acquire share, percentage		55%
MakerBot [Member]
Certain Transactions (Details) [Line Items]
Revaluation of an equity investment	$ 47
NPM Capital [Member]
Certain Transactions (Details) [Line Items]
Revaluation of an equity investment	$ 15.4

Certain Transactions (Details)

Certain Transactions (Details) - Schedule of fair value of the consideration transferred to xaar 3D’s stockholders for the xaar 3D transaction - Xaar 3D [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Sensitivity Analysis of Fair Value of Interests Continued to be Held by Transferor, Servicing Assets or Liabilities, Impact of Adverse Change in Assumption [Line Items]
Cash payments	$ 13,967
Contingent consideration at estimated fair value	15,314
Total consideration for 55% holding	29,281
Fair value of 45% holding	23,775
Total consideration	$ 53,056

Certain Transactions (Details_2

Certain Transactions (Details) - Schedule of fair value of the consideration transferred to xaar 3D’s stockholders for the xaar 3D transaction (Parentheticals) - Xaar 3D [Member]	6 Months Ended
	Jun. 30, 2022
Sensitivity Analysis of Fair Value of Interests Continued to be Held by Transferor, Servicing Assets or Liabilities, Impact of Adverse Change in Assumption [Line Items]
Consideration rate	55%
Fair value rate	45%

Certain Transactions (Details_3

Certain Transactions (Details) - Schedule of preliminary allocation of the purchase price to assets acquired and liabilities $ in Thousands	Jun. 30, 2022 USD ($)
Schedule of preliminary allocation of the purchase price to assets acquired and liabilities [Abstract]
Cash and cash equivalents	$ 82
Goodwill	25,375
Intangible assets	45,000
Other assets	5,280
Total assets acquired	75,737
Net deferred tax liabilities	1,736
Other liabilities	20,945
Total liabilities assumed	22,681
Net assets acquired	$ 53,056

Revenues (Details)

Revenues (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Revenue Recognition [Abstract]
Long term deferred revenue	$ 22.7	$ 22.7	$ 21.1
Revenue recognized	30.5	12.9
Remaining performance obligations	112.7	112.7
Expected remaining performance obligations recognized during next 12 months	89.5	89.5
Expected remaining performance obligations recognized over subsequent 12 months	16.2	16.2
Expected remaining performance obligations recognized remainder thereafter	6.9	6.9
Deferred sales commissions	$ 8.4	$ 8.4	$ 7.4

Revenues (Details) - Schedule o

Revenues (Details) - Schedule of disaggregated by geographical region - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 166,603	$ 147,005	$ 330,032	$ 281,194
Total Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	107,225	92,949	205,792	175,062
Total EMEA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	35,212	32,523	75,267	61,441
Total Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	24,166	21,533	48,973	44,691
Systems [Member] | Total Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	32,868	27,053	61,850	48,410
Systems [Member] | Total EMEA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	14,760	10,481	29,837	20,179
Systems [Member] | Total Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	11,235	8,031	21,693	16,856
Consumables [Member] | Total Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	34,662	30,730	66,016	58,941
Consumables [Member] | Total EMEA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	14,268	15,345	32,093	28,148
Consumables [Member] | Total Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	7,928	8,665	17,305	18,095
Service [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	50,882	46,700	101,238	90,565
Service [Member] | Total Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	39,695	35,166	77,926	67,711
Service [Member] | Total EMEA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	6,184	6,697	13,337	13,114
Service [Member] | Total Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 5,003	$ 4,837	$ 9,975	$ 9,740

Revenues (Details) - Schedule_2

Revenues (Details) - Schedule of revenue recognition - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	$ 166,603	$ 147,005	$ 330,032	$ 281,194
Total revenues recognized in point in time [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	128,868	111,429	254,433	212,354
Total revenues recognized over time [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	37,735	35,576	75,599	68,840
Products [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	115,721	100,305	228,794	190,629
Products [Member] | Total revenues recognized in point in time [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	115,721	100,305	228,794	190,629
Services [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	50,882	46,700	101,238	90,565
Services [Member] | Total revenues recognized in point in time [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	13,147	11,124	25,639	21,725
Services [Member] | Total revenues recognized over time [Member]
Revenues (Details) - Schedule of revenue recognition [Line Items]
Total Revenues	$ 37,735	$ 35,576	$ 75,599	$ 68,840

Revenues (Details) - Schedule_3

Revenues (Details) - Schedule of changes in deferred revenue - USD ($) $ in Thousands		Jun. 30, 2022	Dec. 31, 2021
Schedule of changes in deferred revenue [Abstract]
Deferred revenue	[1]	$ 72,238	$ 72,307
[1]*Includes $22.7 million and $21.1 million under long-term deferred revenue in the Company's consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively.

Inventories (Details) - Schedul

Inventories (Details) - Schedule of inventories - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Schedule of inventories [Abstract]
Finished goods	$ 64,897	$ 58,784
Work-in-process	6,218	4,360
Raw materials	82,587	66,003
Total inventory	$ 153,702	$ 129,147

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 7.7	$ 9.2	$ 18.4	$ 15.2

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets (Details) - Schedule of changes in the carrying amount of goodwill - Goodwill [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Goodwill [Line Items]
Goodwill as of January 1, 2022	$ 65,144
Foreign currency translation adjustments	(185)
Goodwill as of June 30, 2022	$ 64,959

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	$ 515,276	$ 556,994
Accumulated Amortization	(381,619)	(404,750)
Net Book Value	133,657	152,244
Developed technology [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	382,436	406,578
Accumulated Amortization	(269,440)	(279,037)
Net Book Value	112,996	127,541
Patents [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	15,567	16,220
Accumulated Amortization	(8,079)	(8,503)
Net Book Value	7,488	7,717
Trademarks and trade names [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	16,732	26,055
Accumulated Amortization	(13,467)	(22,241)
Net Book Value	3,265	3,814
Customer relationships [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	93,475	100,731
Accumulated Amortization	(83,567)	(87,559)
Net Book Value	9,908	13,172
Capitalized software development costs [Member]
Goodwill and Other Intangible Assets (Details) - Schedule of other intangible assets [Line Items]
Carrying Amount, Net of Impairment	7,066	7,410
Accumulated Amortization	(7,066)	$ (7,410)
Net Book Value

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets (Details) - Schedule of estimated amortization expense relating to intangible assets $ in Thousands	Jun. 30, 2022 USD ($)
Schedule of estimated amortization expense relating to intangible assets [Abstract]
2022	$ 18,705
2023	22,058
2024	18,048
2025	15,577
2026	15,501
2026 and thereafter	43,768
Total	$ 133,657

Net Loss Per Share (Details)

Net Loss Per Share (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of net loss per share	5.2	5.1	5.2	5.1

Net Loss Per Share (Details) -

Net Loss Per Share (Details) - Schedule of basic and diluted net loss per share - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net loss for basic and diluted net loss per share	$ (24,385)	$ (20,159)	$ (45,333)	$ (39,070)
Denominator:
Weighted average shares - for basic and diluted net loss per share	66,568	64,908	66,151	61,796
Net loss per share
Basic and diluted	$ (0.37)	$ (0.31)	$ (0.69)	$ (0.63)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income tax expense benefits	$ 0.4	$ 4.4	$ 0.5	$ 5.3

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Accrued expenses and other current liabilities	$ 4.8	$ 2.4

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of assets and liabilities carried at fair value on a recurring basis - USD ($) $ in Thousands		Jun. 30, 2022	Dec. 31, 2021
Fair Value, Inputs, Level 2 [Member] | Assets [Member]
Assets:
Foreign exchange forward contracts not designated as hedging instruments		$ 244	$ 82
Foreign exchange forward contracts designated as hedging instruments		2,295	910
Fair Value, Inputs, Level 2 [Member] | Liabilities [Member]
Liabilities:
Foreign exchange forward contracts not designated as hedging instruments		(82)	(89)
Foreign exchange forward contracts designated as hedging instruments		(2,715)	(60)
Total contingent consideration	[1]
Foreign exchange forward contracts fair value		(258)	843
Fair Value, Inputs, Level 3 [Member] | Assets [Member]
Assets:
Foreign exchange forward contracts not designated as hedging instruments
Foreign exchange forward contracts designated as hedging instruments
Fair Value, Inputs, Level 3 [Member] | Liabilities [Member]
Liabilities:
Foreign exchange forward contracts not designated as hedging instruments
Foreign exchange forward contracts designated as hedging instruments
Total contingent consideration	[1]	55,108	55,919
Foreign exchange forward contracts fair value		$ 55,108	$ 55,919
[1]Includes $4.8 million and $2.4 million under Accrued expenses and other current liabilities in the Company's consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively.

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities (Details) € in Millions, ₪ in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 ILS (₪)	Jun. 30, 2022 EUR (€)
Derivative Instruments and Hedging Activities (Details) [Line Items]
Notional amount of derivative asset	$ 41.6		$ 41.6
Gain (Loss) on derivative instrument	$ 2.4	$ 0.5	$ 3.1	$ 1.7
Conversion to NIS [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities (Details) [Line Items]
Notional amount of derivative asset | ₪					₪ 35.1
Conversion to Euro [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities (Details) [Line Items]
Notional amount of derivative asset | €						€ 27.4

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Details) - Schedule of balance sheet classification and fair values of derivative instruments - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Fair value	$ (258)	$ 843
Notional amount	104,173	132,155
Foreign exchange contracts [Member] | Other current assets [Member] | Not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative asset	244	82
Notional amount of derivative asset	39,197	12,380
Foreign exchange contracts [Member] | Other current assets [Member] | Designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative asset	2,295	910
Notional amount of derivative asset	27,434	60,408
Foreign exchange contracts [Member] | Accrued expenses and other current liabilities [Member] | Not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative liability	(82)	(89)
Notional amount of derivative liability	2,421	33,047
Foreign exchange contracts [Member] | Accrued expenses and other current liabilities [Member] | Designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Fair value derivative liability	(2,715)	(60)
Notional amount of derivative liability	$ 35,121	$ 26,320

Equity (Details)

Equity (Details) $ in Millions	1 Months Ended		3 Months Ended	6 Months Ended
	Jul. 24, 2022	Oct. 31, 2021	Mar. 31, 2021 USD ($) shares	Jun. 30, 2022 USD ($)	Jun. 30, 2022 ₪ / shares
Equity (Details) [Line Items]
Salaries to purchase ordinary shares, percentage	0.01%	15%
Fair market value		85%
Long-Term Debt, Term	364 years
acquires percentage				15%
Ordinary shares, par value (in New Shekels per share) | ₪ / shares					₪ 0.01
Existing holder of ordinary shares				15%
Public offering of ordinary shares, net (in Dollars)			$ 218.9
Deferred tax asset (in Dollars)				$ 1.3
Rights Plan [Member]
Equity (Details) [Line Items]
Ownership percentage	15%
Ordinary Shares [Member]
Equity (Details) [Line Items]
Sale of public offering shares (in Shares) | shares			7,931,034
Stock Option [Member]
Equity (Details) [Line Items]
Unrecognized compensation cost (in Dollars)				$ 1.6
Weighted-average period				2 years 6 months 18 days
RSUs and PSUs [Member]
Equity (Details) [Line Items]
Unrecognized compensation cost (in Dollars)				$ 72
Weighted-average period				2 years 7 months 28 days

Equity (Details) - Schedule of

Equity (Details) - Schedule of stock-based compensation expenses - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Cost of revenues [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 1,080	$ 788	$ 1,980	$ 1,422
Research and development, net [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	1,606	1,870	3,392	3,294
Selling, general and administrative [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	6,145	5,319	11,992	10,466
Total stock-based compensation expenses [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 8,831	$ 7,977	$ 17,364	$ 15,182

Equity (Details) - Schedule o_2

Equity (Details) - Schedule of stock option activity	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Stockholders' Equity Note [Abstract]
Number of Options, Options outstanding | shares	1,732,368
Weighted Average Exercise Price, Options outstanding | $ / shares	$ 28.85
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Number of Options, Exercised | shares	(21,240)
Weighted Average Exercise Price, Exercised | $ / shares	$ 11.58
Number of Options, Forfeited | shares	(22,793)
Weighted Average Exercise Price, Forfeited | $ / shares	$ 23.06
Number of Options, Options outstanding | shares	1,688,335
Weighted Average Exercise Price, Options outstanding | $ / shares	$ 29.15
Number of Options, Options exercisable | shares	1,374,113
Weighted Average Exercise Price, Options exercisable | $ / shares	$ 32.04

Equity (Details) - Schedule o_3

Equity (Details) - Schedule of RSUs and PSUs activity - Restricted and Phantom Share Units [Member]	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Equity (Details) - Schedule of RSUs and PSUs activity [Line Items]
Number of RSUs and PSUs, Unvested | shares	3,082,798
Weighted Average Grant Date Fair Value, Unvested | $ / shares	$ 26.36
Number of RSUs and PSUs, Granted | shares	1,741,710
Weighted Average Grant Date Fair Value, Granted | $ / shares	$ 22.43
Number of RSUs and PSUs, Vested | shares	(1,030,907)
Weighted Average Grant Date Fair Value, Vested | $ / shares	$ 25.04
Number of RSUs and PSUs, Forfeited | shares	(248,657)
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	$ 24.56
Number of RSUs and PSUs, Unvested | shares	3,544,944
Weighted Average Grant Date Fair Value, Unvested | $ / shares	$ 24.94

Equity (Details) - Schedule o_4

Equity (Details) - Schedule of accumulated other comprehensive income (loss) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (8,771)	$ (8,846)
Other comprehensive income before reclassifications		1,852
Other comprehensive income (loss) before reclassifications	(4,540)
Amounts reclassified from accumulated other comprehensive loss	(43)	291
Other comprehensive income (loss)	(4,583)	2,143
Ending balance	(13,354)	(6,703)
Net Unrealized Gain (Loss) on Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	1,572	(1,673)
Other comprehensive income before reclassifications		1,710
Other comprehensive income (loss) before reclassifications	(1,049)
Amounts reclassified from accumulated other comprehensive loss	(43)	291
Other comprehensive income (loss)	(1,092)	2,001
Ending balance	480	328
Foreign Currency Translation Adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(10,343)	(7,173)
Other comprehensive income before reclassifications		142
Other comprehensive income (loss) before reclassifications	(3,491)
Amounts reclassified from accumulated other comprehensive loss
Other comprehensive income (loss)	(3,491)	142
Ending balance	$ (13,834)	$ (7,031)